Page 1 | Search Results | Blood | American Society of Hematology

Skip to Main Content

Skip Nav Destination

1-4 of 4

Sort by

Sort Order Select

Journal Articles

CD27-Armored BCMA-CAR T Cell (CBG-002) Therapy for Relapsed and Refractory Multiple Myeloma: A Phase I Clinical Trial

Yang Xu, Xuzhao Zhang, Dijia Xin, Jiawei Zhang, Luyao Wang, Yili Fan, Boxiao Chen, Wen Lei, Xi Qiu, Huawei Jiang, Xibin Xiao, Liansheng Huang, Wenjun Yang, Jiangao Zhu, Wenbin Qian

Blood (2023) 142 (Supplement 1): 3468.

https://doi.org/10.1182/blood-2023-174364

Published: 2023

Journal Articles

A Phase 1 Study of RJMty19: Anti-CD19 Humanized CAR-Engineered Allogeneic Double Negative T Cells in Adults with B-Cell Non-Hodgkin's Lymphoma

Xibin Xiao, Wen Lei, Huawei Jiang, Xi Qiu, Xian Li, Panpan Chen, Yang Xu, Haicun Xie, Guangrong Song, Yu Cheng, Fuqiang Wu, Daqing Liu, Liming Yang, Wenbin Qian

Blood (2023) 142 (Supplement 1): 2094.

https://doi.org/10.1182/blood-2023-189149

Published: 2023

Journal Articles

Safety and Feasibility of Anti-CD19 CAR-T Expressing IL-7 and CCL19 in Patients with Relapsed or Refractory Large B-Cell Lymphoma

Wen Lei, Zhao Ai, Hui Liu, Chunmei Yang, Cheng Wei, Shanshan Guo, Zhilu Chen, Qunyi Guo, Linjie Li, Mingzhe Zhao, Gongqiang Wu, Jinyi Zhang, Jimin Gao, Wenbin Qian

Blood (2022) 140 (Supplement 1): 12722.

https://doi.org/10.1182/blood-2022-156635

Published: 2022

Journal Articles

Safety and Efficacy of CD19 CAR-T Cells Co-Expressing IL-7 and CCL19 in Combination with Anti-PD-1 Antibody for Refractory/Relapsed DLBCL: Preliminary Data from the Phase Ⅰb Trial (NCT04381741)

Wenbin Qian, Aiqi Zhao, Hui Liu, Wen Lei, Yun Liang, Xianggui Yuan

Blood (2021) 138 (Supplement 1): 3843.

https://doi.org/10.1182/blood-2021-144523

Published: 2021